171 related articles for article (PubMed ID: 30625093)
1. [Not Available].
Mansurova JA; Karazhanova LK
Kardiologiia; 2018 Dec; 58(12):22-29. PubMed ID: 30625093
[TBL] [Abstract][Full Text] [Related]
2. Independent predictors of acute kidney injury in patients with acute coronary syndrome after percutaneous coronary intervention.
Zhunuspekova A; Mansurova J; Karazhanova L
PLoS One; 2021; 16(3):e0247304. PubMed ID: 33661913
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of acute cardiorenal syndrome in patients with acute cardiac pathology].
Mezhonov EM; Vyalkina JA; Shalaev SV
Kardiologiia; 2019 Sep; 59(8S):44-55. PubMed ID: 31526361
[TBL] [Abstract][Full Text] [Related]
4. [Not Available].
Erlikh AD
Kardiologiia; 2018 Dec; 58(12):13-21. PubMed ID: 30625092
[TBL] [Abstract][Full Text] [Related]
5. [Multifactorial Prognostication of the Development of Stent Thrombosis in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention on the background of Dual Antiplatelet Therapy].
Korotaeva ES; Koroleva LY; Nosov VP; Kovaleva GV; Kuzmenko EA
Kardiologiia; 2019 Dec; 59(11):5-13. PubMed ID: 31849294
[TBL] [Abstract][Full Text] [Related]
6. [Role of markers of inflammation and endothelial dysfunction in the prognosis of the development of cardiovascular complications in patients with coronary artery disease and metabolic syndrome after coronary stenting].
Svarovskaya AV; Teplyakov AT; Gusakova AM; Garganeeva AA
Kardiologiia; 2020 Sep; 60(8):98-105. PubMed ID: 33155965
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
[TBL] [Abstract][Full Text] [Related]
8. High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.
Parodi G; Marcucci R; Valenti R; Gori AM; Migliorini A; Giusti B; Buonamici P; Gensini GF; Abbate R; Antoniucci D
JAMA; 2011 Sep; 306(11):1215-23. PubMed ID: 21934054
[TBL] [Abstract][Full Text] [Related]
9. The relationship between on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes in Chinese patients.
Tang N; Yin S; Sun Z; Xu X; Qin J
Scand J Clin Lab Invest; 2015 May; 75(3):223-9. PubMed ID: 25594796
[TBL] [Abstract][Full Text] [Related]
10. The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation.
Liang ZY; Han YL; Zhang XL; Li Y; Yan CH; Kang J
EuroIntervention; 2013 Jul; 9(3):316-27. PubMed ID: 23872648
[TBL] [Abstract][Full Text] [Related]
11. Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
Nardin M; Verdoia M; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):567-574. PubMed ID: 27134063
[TBL] [Abstract][Full Text] [Related]
12. [Predicting the development of adverse events in patients with acute coronary syndrome including genetics in the long-term follow-up].
Shmidt EA; Berns SA; Ponasenko AV; Klimenkova AV; Tumanova SA; Litvinova MN; Barbarash OL
Kardiologiia; 2020 Mar; 60(4):77-85. PubMed ID: 32394861
[TBL] [Abstract][Full Text] [Related]
13. Variability of platelet response to clopidogrel is not related to adverse cardiovascular events in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
Olędzki S; Kornacewicz-Jach Z; Safranow K; Kiedrowicz R; Gawrońska-Szklarz B; Jastrzębska M; Gorący J
Eur J Clin Pharmacol; 2017 Sep; 73(9):1085-1094. PubMed ID: 28589365
[TBL] [Abstract][Full Text] [Related]
14. High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy.
Leé S; Vargová K; Hizoh I; Horváth Z; Gulácsi-Bárdos P; Sztupinszki Z; Apró A; Kovács A; Préda I; Tóth-Zsámboki E; Kiss RG
Thromb Res; 2014 Feb; 133(2):257-64. PubMed ID: 24359966
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial).
Patti G; Pasceri V; Mangiacapra F; Colonna G; Vizzi V; Ricottini E; Montinaro A; D'Ambrosio A; Wijns W; Barbato E; Di Sciascio G;
Am J Cardiol; 2013 Jul; 112(2):162-8. PubMed ID: 23601577
[TBL] [Abstract][Full Text] [Related]
16. A comparative evaluation of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Dasbiswas A; Rao MS; Babu PR; Vijayvergiya R; Nayak R; Dani S; Tyagi S; Hiremath S; Patel T; Alexander T; Prakash VS; Singh DP; Yadav MK; Pathak K; Srivastava A
J Assoc Physicians India; 2013 Feb; 61(2):114-6, 126. PubMed ID: 24471250
[TBL] [Abstract][Full Text] [Related]
17. The impact of a 600-mg loading dose of clopidogrel in diabetic and non-diabetic patients undergoing elective PCI.
Mohareb MW; Abd Elghany M; Sabry NA; Farid SF
Minerva Cardioangiol; 2016 Aug; 64(4):375-82. PubMed ID: 25029567
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP.
Moerenhout CM; Claeys MJ; Haine S; Miljoen H; Bosmans JM; Vertessen F; Kluppels K; Van der Planken M; Vrints CJ
Am Heart J; 2010 Mar; 159(3):434-8. PubMed ID: 20211306
[TBL] [Abstract][Full Text] [Related]
19. [High On-Treatment Platelet Reactivity Determinants on Dual Antiplatelet Therapy in Patients With Ischemic Heart Disease Before Elective Percutaneous Coronary Intervention].
Golukhova EZ; Grigoryan MV; Ryabinina MN; Bulaeva NI
Kardiologiia; 2018 Apr; (4):5-14. PubMed ID: 29782255
[TBL] [Abstract][Full Text] [Related]
20. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
